Muscle Physiology III Flashcards

1
Q

inc. Ca++ n the Myosin Light

Chain Kinase

A
-Myosin Light
Chain Kinase
activated
-phophoryte 
-CONTRACTION
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Smooth muscle contraction -Myosin II:

A
  • 2 myosin heavy chain
  • 2 myosin light chains (MLC):
  • Essential MLC
  • Regulator MLC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Smooth muscle contraction component

A

Myosin light chain kinase (MLCK)
Myosin light chain phosphatase (MLCP)
Calmodulin (regulator of contraction; homologous of Troponin C)
Ca++ (activator of contraction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Voltage-gated 1,4 dihydropyridine calcium channels

A

Electromechanical coupling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ligand-gated calcium channels

A

Pharmacomechanical coupling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stretch-activated calcium channels

A

Myogenic regulation in arterioles (microvascular resistance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Leak calcium channels

A

Unregulated

Mechanical stretch promotes inward movement of Ca++

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ca++ channel bocer

A

-Inhibit voltage-dependent L-type calcium channels - Dec .muscle contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dihydropyridine CCB

A

-Act on vascular smooth muscle
Amlodipine, clevidipine, nicardipine, nifedipine, nimodipine
Clinical use: Hypertension, prevention of cerebral vasospasm (nimodipine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-dihydropyridine CCB

A

-Act on heart:
-Diltiazem, verapamil
Clinical use: atrial fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cAMP pathway

A

-Enhances Ca++
reuptake
-RELAXATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Beta-2 receptors are Gs-protein coupled:

A

Bronchial smooth muscle relaxation (bronchodilation)
โ€ข Uterine smooth muscle relaxation during pregnancy
โ€ข Blood vessels relaxation (vasodilation) in the skeletal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Albuterol, levalbuterol, salmeterol, salbutamol (inhalation)

A

Bronchial smooth muscle relaxation โ€“Bronchodilation

Clinical use: Bronchial Asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Terbutaline

A

Uterine smooth muscle relaxation in pregnant women โ€“Tocolysis
Clinical use: premature labor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

milrinone

A
Selective PDE-3 inhibitor
Phosphodiesterase 3 (PDE-3) converts cAMP into AMP in cardiac and smooth muscle
-Clinical use: short-term use in acute decompensated Heart Failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

milrinone -In cardiomyocytes:

A

inc . cAMP - inc. Ca++ influx - inc. Inotropy and Chronotropy

17
Q

milrinone -In vascular smooth muscle

A

inc. cAMP โ€“ Inhibition of MLCK activity โ€“ General Vasodilation

18
Q
Nitric Oxide (NO)
pathway
A

-cGMP
-Open K+ channels:
hyperpolarization
-Inhibit Ca++ entry
-MLCP

19
Q

Nitrates

A

Increase Nitric Oxide in vascular smooth muscle
Dilate veins&raquo_space; arteries โ€ฆโ€ฆ Decrease PRELOAD
Nitroglycerine, isosorbide denitrate, isosorbide mononitrate
Clinical use: angina, acute coronary syndrome

20
Q

Hydralazine

A

inc. cGMP โ€“vascular smooth muscle relaxation
Dilate arterioles > veins โ€ฆโ€ฆ Decrease AFTERLOAD
Clinical use: severe hypertension (acute treatment); safe during pregnancy

21
Q

Nitroprusside

A

inc. cGMP โ€“vascular smooth muscle relaxation

22
Q

Ca++ RELEASE

A
  • CICR
  • IP3
  • Contraction
23
Q

mechanism o RELAXATION

A
  • dec. Ca++

- dec. MLCK activity

24
Q

mechanism o RELAXATION-Cell repolarization

A

Decrease influx of Ca++

25
Q

mechanism o RELAXATION-Reuptake of Ca++ to the SR:

A

SERCA pump

26
Q

mechanism o RELAXATION-Plasma Membrane Ca++ ATPase Pump

A

Promote Ca++ efflux

27
Q

mechanism o RELAXATION-Na+/Ca++ exchange mechanism

A

Promote Ca++ efflux

28
Q

Latch mechanism or state

A

ns its full force of contraction despite reduced amount of
continuing excitation and lesser energy required for comparable sustained skeletal
muscle contraction
-Low ATP utilization
โ€ข Lower Ca++ concentration requirements

29
Q

Latch mechanism or state-Importance

A

can maintain prolonged tonic contraction in smooth muscle for
hours with little use of energy

30
Q

Latch mechanism or state-Cause (hypothesis):

A

myosin dephosphorylation while still attached to actin during
the crossbridge cycle

31
Q

Ca++ sensitization

A

Decrease MLCP activity โ€“ Increase MLC phosphorylation

32
Q

Ca++ de-sensitization

A

Increase MLCP activity โ€“ Decrease MLC phosphorylation